文献速递乳腺癌支持与姑息治疗

转移性乳腺癌患者姑息治疗实施的年龄差异:ESME-MBC队列分析

Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
PubMed 文献 · Eur J Cancer · 2020-08-14

该研究基于法国18家综合癌症中心ESME-MBC队列中12,375例转移性乳腺癌患者,评估住院姑息治疗(IPC)的累积发生率函数(CIF)及年龄的影响。中位随访41.5个月,IPC的2年和8年CIF分别为10.3%和24.8%;年龄对IPC实施的影响因肿瘤亚型和中心规模而异。

要点

  • MBC患者IPC的2年CIF为10.3%,8年为24.8%,整体水平相对较低
  • 三阴性且<65岁患者短期IPC需求更高,非三阴性则≥65岁患者更高
  • 大型中心以外诊断的老年患者长期IPC接受更少

核心结论

  • 转移性乳腺癌患者IPC的CIF相对较低,年龄影响IPC实施。
  • 年轻三阴性和老年非三阴性患者需要更多短期IPC。
  • 在大型中心以外诊断的老年患者接受的长期IPC更少。

研究设计与样本

  • 全国性ESME-MBC队列,纳入18家法国综合癌症中心连续治疗的转移性乳腺癌患者。
  • 分析纳入12,375例患者,其中5,093例(41.2%)年龄≥65岁。
  • 采用ICD-10姑息治疗编码识别住院姑息治疗(IPC)。
  • 中位随访41.5个月(95%CI 40.5-42.5)。

主要发现

  • IPC的CIF在2年为10.3%(95%CI 10.2-10.4),8年为24.8%(95%CI 24.7-24.8)。
  • 2年时三阴性患者中,校正肿瘤特征、中心和时期后,<65岁者IPC的CIF高于≥65岁者(65+/<65:β=-0.05;95%CI -0.08至-0.01)。
  • 其他肿瘤亚型中,≥65岁患者较年轻患者更常接受短期IPC(65+/<65:β=0.02;95%CI 0.01-0.03)。
  • 8年时在大型中心以外,校正肿瘤特征和时期后老年患者IPC实施更少(65+/<65:β=-0.03;95%CI -0.06至-0.01)。

临床怎么用

  • 提示需更广泛地建设住院姑息治疗设施。
  • 提示需针对不同年龄与肿瘤亚型制定年龄特异性干预策略。
  • 关注大型中心以外老年患者的长期IPC可及性。

局限性

  • 为观察性队列分析,IPC识别依赖ICD-10编码。
  • 仅纳入法国18家综合癌症中心患者,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with metastatic breast cancer (MBC) often require inpatient palliative care (IPC). However, mounting evidence suggests age-related disparities in palliative care delivery. This study aimed to assess the cumulative incidence function (CIF) of IPC delivery, as well as the influence of age. METHODS: The national ESME (Epidemio-Strategy-Medical-Economical)-MBC cohort includes consecutive MBC patients treated in 18 French Comprehensive Cancer Centres. ICD-10 palliative care coding was used for IPC identification. RESULTS: Our analysis included 12,375 patients, 5093 (41.2%) of whom were aged 65 or over. The median follow-up was 41.5 months (95% confidence interval [CI], 40.5-42.5). The CIF of IPC was 10.3% (95% CI, 10.2-10.4) and 24.8% (95% CI, 24.7-24.8) at 2 and 8 years, respectively. At 2 years, among triple-negative patients, young patients (<65 yo) had a higher CIF of IPC than older patients after adjusting for cancer characteristics, centre and period (65+/<65: β = -0.05; 95% CI, -0.08 to -0.01). Among other tumour sub-types, older patients received short-term IPC more frequently than young patients (65+/<65: β = 0.02; 95% CI, 0.01 to 0.03). At 8 years, outside large centres, IPC was delivered less frequently to older patients adjusted to cancer characteristics and period (65+/<65: β = -0.03; 95% CI, -0.06 to -0.01). CONCLUSION: We found a relatively low CIF of IPC and that age influenced IPC delivery. Young triple-negative and older non-triple-negative patients needed more short-term IPCs. Older patients diagnosed outside large centres received less long-term IPC. These findings highlight the need for a wider implementation of IPC facilities and for more age-specific interventions.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Frasca M, Sabathe C, Delaloge S, et al. Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016. Eur J Cancer. 2020. PMID: 32805641. doi:10.1016/j.ejca.2020.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。